Unravelling the Impact of Bolsa Família Program on Birth Weight Indicators in Brazil

By Staff Writer

December 6, 2023

Introduction

Birth weight and gestational age are vital indicators of newborn health. Low birth weight (LBW) is a concern. Especially in low and middle-income countries, as it poses short and long-term health risks. In Brazil, approximately 8.7% of live births are considered LBW. This statistic that hasn’t significantly decreased over the last 15 years. This study examines the impact of Bolsa Família Program (BFP) on Birth Weight in Brazil, a conditional cash transfer (CCT) program in Brazil, that impacts these birth weight indicators.

Impact of Bolsa Família Program on Birth Weight in Brazil

The BFP, one of the world’s pioneering CCTs, benefits over 13 million families per year. In the 1990s, the strategy was initiated for social protection and poverty reduction. Unlike unconditional cash transfer programs that provide only monetary transfers, CCTs require adherence to a health and education agenda for continued receipt. This requirement may lead to reductions in barriers to accessing services, increased income and food access, and, consequently, promotion of maternal and child health.

The Study Population and the Exposure

The study focused on children born from live births in the Centro de Integracao de Dados e Conhecimentos Para Saude (CIDACS) Birth Cohort from 2012 to 2015. The mothers were aged between 10 and 49 years and were registered on CadÚnico, the Brazilian national social program register. The study considered births that occurred between 2012 and 2015 due to a change to birth certificates in 2011. The births were classified based on whether the mother started receiving BFP during the cohort period.

Findings

The study found that BFP participation was associated with reduced chances of LBW and an increase in birth weight in grams. The impact was greater among higher-risk population subgroups, such as mothers who attended fewer than seven antenatal care appointments, were Black, Indigenous, or Parda, and less educated. They found an association among Indigenous mothers and those with less education, where participation in BFP decreased the odds of small for gestational age. 

Conclusions

The study found an association between BFP participation and improved birth weight indicators, particularly in higher-risk groups. This highlights the importance of maintaining financial support. Especially for high-risk mothers and reducing barriers to access and use of health services. Future studies may also assess the quality of prenatal care provided to socioeconomically high-risk populations.

Reference url

Recent Posts

lenacapavir HIV PrEP access
    

Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prevention

💉 How can we ensure equitable access to HIV prevention methods like lenacapavir?

A recent initiative from the Global Fund, supported by key global health organizations, aims to provide affordable access to this new HIV pre-exposure prophylaxis medication.

With a goal to reach 2 million individuals over three years, this coordinated effort seeks to drastically cut HIV infections and align with our commitment to ending AIDS by 2030.

Explore the details of this impactful collaboration and how it could transform HIV prevention.

#SyenzaNews #globalhealth #HealthcareInnovation #MarketAccess

antimicrobial resistance africa
     

Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak

🌍 Are we prepared to tackle the hidden pandemic of antimicrobial resistance (AMR) in Africa?

With AMR rapidly becoming a dominant health crisis, it’s critical to understand its impact on our healthcare systems and most vulnerable populations.

The Africa CDC highlights the urgent need for substantial investment and coordinated responses to combat this escalating threat, alongside the ongoing Mpox outbreak.

Discover the pressing challenges and potential solutions in our latest article.

#SyenzaNews #GlobalHealth #HealthcareInnovation #AntimicrobialResistance #PublicHealth

BioSapien cancer drug delivery
    

BioSapien Innovative Cancer Drug Delivery Solutions

🌟 How is innovation in drug delivery shaping the future of cancer treatment? 🌟

Discover how UAE-based BioSapien is transforming the healthcare landscape with the MediChip™ platform, securing $5.5 million in pre-Series A funding to enhance cancer care.

This innovative solution promises to minimise side effects and improve treatment outcomes for patients, fully embracing the potential of biotechnology in the fight against cancer.

Read more about BioSapien’s journey and its impact on global health!

#SyenzaNews #biotechnology #oncology #innovation #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.